Skip to Content



Jan. 24, 2012

Forming a global cancer network for research, clinical care, education and prevention.

Contact GAPConnect.


Polish Cancer Consortium - An Introduction

At Global Academic Programs' most recent Oversight Steering Committee meeting, Waldemar Priebe, Ph.D., professor in the Department of Experimental Therapeutics, presented on possible future Sister Institution, The Polish Cancer Consortium. The proposed consortium would include:

  • Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch – This center is one of the largest clinical institutions in Poland and comprises more than 200 researchers and clinicians. The research focus is mainly translational and centers on molecular diagnostics and experimental therapeutics. The center contributes to three graduate programs at Silesian University.
  • Silesian University of Technology – A 65-year-old institution with an enrollment of 30,000 students, making it one of the largest technical universities in Poland. The school offers engineering instruction in 48 disciplines.
  • Polish Academy of Sciences - Institutes of Biochemistry and Biophysics, and Experimental Medicine – Acts as a state scientific institution and a scientific advisory board. The Academy has national and foreign members elected by the Polish General Assembly. Comprising 79 research establishments, the Academy is funded mainly by the Polish Ministry of Science and Higher Education.
  • University of Warsaw – Poland's largest university with more than 53,000 students. Nineteen different colleges cover all topics, but a relationship would focus on pertinent disciplines.

The four institutions cooperatively agreed to form a consortium for the express purpose of collaborating with MD Anderson as a Sister Institution. The individual members of the consortium have engaged in past or ongoing research with MD Anderson in the fields of radiation oncology, reconstructive microsurgery, melanoma, drug design, molecular modeling, structural biology, drug synthesis and commercialization of novel therapies. At a future Oversight Steering Committee, GAP staff will provide a full presentation on the Polish Cancer Consortium and the members of the committee will have a chance to vote on creating a Sister Institution.

Calendar of Events

CMSI Annual Symposium
Tokyo, Japan
Feb. 27, 2012

MD Anderson Espana Conference
Madrid, Spain
March 14-16, 2012

GAP Annual Conference
Oslo, Norway
May 14-16, 2012


CMSI Annual Symposium 2012

The University of Tokyo's Center for Medical System Innovation (CMSI) will host its annual symposium on Monday, Feb. 27, 2012. Oliver Bögler, Ph.D., vice president of Global Academic Programs, will present at the symposium as he has since 2010. Also invited as a special guest is Raymond DuBois, M.D., Ph.D., provost and executive vice president of MD Anderson, who will present the Keynote Speech at the fourth year of the symposium. CMSI is a Global Center of Excellence. The Japanese government awards these COEs as five-year programs to top Japanese universities. The intent of the COEs and CMSI is to bring together cross-disciplinary research teams to work on various problems. For CMSI those issues center on public health. To foster this research, CMSI enables graduate exchange of Japanese students with universities around the world, including MD Anderson. While the CMSI exchange is a summer program, these graduate students often pursue longer-term research as well. GAP Connect recently ran a story about two such students who have returned repeatedly to work at MD Anderson as a result of their initial CMSI exchange.

Joint MD Anderson Conference in Spain

From March 14-16, 2012, physicians at The University of Texas MD Anderson Cancer Center and MD Anderson Cancer Center - España will gather in Madrid to hold the III MD Anderson International Conference in Gynecologic Oncology. Entitled Designing the Future, the conference will be directed by MD Anderson - España physicians Luis Chiva, M.D., chief of the Department of Gynecologic Oncology and Antonio González Martin, M.D., chief of the Department of Medical Oncology, as well as MD Anderson's Pedro Ramirez, M.D., professor in the Department of Gynecologic Oncology & Reproductive Medicine. The conference will cover topics including the molecular biology of gynecologic cancer, principles of translational research, integrating targeted therapy into clinical practice, minimally invasive and conservative surgery, and controversies in the field. David Gershenson, M.D., chairman of MD Anderson's Department of Gynecologic Oncology will provide the keynote lecture for the event. The final conference agenda will appear in GAP Connect as the conference draws closer.

Network News

Visiting Professorship in Gynecologic Oncology Continues Efforts

The program, sponsored by the American Congress of Obstetricians and Gynecologists (ACOG) and the International Gynecologic Cancer Society (IGCS) continues to travel to Central America to provide training for residents. This week, Kathleen Schmeler, M.D., assistant professor in the Department of Gynecologic Oncology and Reproductive Medicine at MD Anderson and Mildred Chernofsky, M.D., a Washington D.C. area gynecologic oncologist named to the US News & World Report "Top Doctors" list for 2012, will be travelling to San Salvador, El Salvador. While in El Salvador, the two physicians will lecture residents and attendings and assist in surgical procedures at Hospital Maternidad.

Barretos Cancer Hospital's Foundation Chooses New Prevention Institute's Site

Earlier this month, leadership from Barretos Cancer Hospital's Foundation chose Ji-Paraná, a city in the state of Rondônia, Brazil, as the site of a new Institute of Cancer Prevention. The total project is valued at $10 million USD, of which more than $3 million USD will be used to purchase, maintain, and run mobile prevention trailers. The Institute will provide diagnostic testing and screening as well as certain smaller surgeries, while the mobile trailers will provide many of the same services to the more remote areas of Rondônia and surrounding states. Barretos Cancer Hospital in Barretos, Brazil, is well-known for its mobile prevention and screening trailers and for providing a place for the underserved to seek cancer treatment.